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Multiple sclerosis (MS)' is a chronic, inflammatory, demyelinating disease of
the central nervous system (CNS) that has been postulated to be a T cell-
mediated autoimmune disorder (1, 2). At sites of active demyelination, the
majority of infiltrating cells are T cells and macrophages, with smaller numbers
of B cells (1). In the cerebrospinal fluid (CSF), >85% of cells are T lymphocytes
(3). The Igs in both the brain and CSF of MS patients can be electrophoretically
resolved into a few bands (oligoclonal banding) and are thought to be synthe-
sized within the CNS by an oligoclonal population of B cells (4, 5). The antigenic
specificity of the T cells in the CSF compartment in subjects with MS is
unknown.
Two possibilities exist concerning the population of T cells that are present in
the CSF of MS patients: (a) the T cells have multiple antigenic specificities and
are derived from a large number of progenitor cells (polyclonal T cells) ; or (b)
there are only a few specificities, derived from a small number of progenitor T
cells (oligoclonal T cells) or from a single common ancestral cell (clonal T cells) .
Clonal T cell expansion has been observed in T cell malignancies (6) but not in
a nonmalignant inflammatory disease.
Whether two T cells are in fact identical and derived from a common ancestral
cell can be determined by analysis of their TCR gene rearrangements using
Southern blotting techniques (7, 8). Identical clones contain identically rear-
ranged TCR genes and have identically sized restriction fragments after enzyme
digest of DNA and hybridization with different TCR gene probes. To determine
by Southern blot analysis whether different CSF-derived T cells are related to
one another, it is necessary to expand the original T cell population without
unintentional growth of some T cells and not others. Others have demonstrated
the clonogenic potential of most every human peripheral blood T cell by grow-
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ing them in vitro in the presence of PHA, irradiated autologous mononuclear
"feeder" cells, and IL-2 (9). Using an identical methodology, we have been able
to clone individual T cells from the CSF with high efficiency (10) .
In the present study, T cell populations were examined by cloning individual
CSF and peripheral blood T cells before other in vitro manipulation. The T cells
were compared with one another by analyzing the pattern of T cell rearrange-
ments in each clone to examine whether clonal T cell expansion can occur in
immune compartments in nonmalignant inflammatory diseases.
Materials and Methods
Patient Population.
￿
The characteristics of the five patients studied are presented in
Table I. Chronic progressive MS patients (GR and KA) had clinically definite disease and
were in the progressive phase as defined by a decline in the previous 9 mo of at least
one grade on the Kurtzke disability status scale (11). Patient MU had an acute, fatal,
atypical 8-mo course of MS and had received a 12-d, 8-g course of intravenous cyclo-
phosphamide plus intravenous adrenocorticotropic hormone 2 mo before the lumbar
puncture to obtain CSF. Patient WI had subacute sclerosing panencephalitis (SSPE) on
the basis of clinical examination and characteristic EEG and spinal fluid examination with
high levels of antimeasles antibody (12) . Patient VE had herpes zoster virus (HZV) men-
ingoencephalitis (13) that was serologically confirmed by an ELISA analysis of serum and
CSF for HZV. The subject with HZV meningoencephalitis had a CSF cell count of 40
lymphocytes/mm'; the other subjects had between 1 and 4 lymphocytes/mms. Except for
subject MU, no patient had received steroids for 1 mo or immunosuppressive medication
for 1 yr before the time of blood drawing and lumbar puncture.
Single Cell T Lymphocyte Cloning.
￿
Peripheral mononuclear cells (MNC) and CSF MNC
were prepared according to standard techniques (10). Peripheral or CSF MNC were
diluted and plated at C 1 cell/well in 100 kl of tissue culture medium containing 106/ml
irradiated (5,000 rad) autologous, mononuclear feeder cells and purified PHA (Well-
come Research Laboratories, Beckenham, England) at a final concentration of 0.5 ug/
ml in V-bottomed 96-well plates (Flow Laboratories, Inc., McLean, VA) (10). At 48 h,
100 Al of either l0°ó T cell growth factor (TCGF) (10) or 5% IL-2 (Advanced Biotech-
nologies, Silver Spring, MD) was added to each well. Plates were fed every 4 d and sam-
ples wells were counted to monitor cell growth. Between days 10 and 14, cells were trans-
ferred from V-bottomed wells to round-bottomed 96-well plates with 105 irradiated,
TABLE I
T Cell Clonality in Cerebrospinal Fluid
* The number of T cell clones demonstrating common sets of unique TCR gene arrangements are
shown.
Subject Disease Age Sex Duration
of disease
Oligoclonal
bands
T cell clonality
CSF Blood
yr
GR Chronic progressive MS 34 F 10 yr Yes 18/28 2/26
KA Chronic progressive MS 36 F 8 yr No 5/27 0/6
MU Acute MS 39 M 8 mo One band 0/37 0/41
WI SSPE 16 F 6 mo Yes 0/33 0/34
VE HZV 63 M 1 mo No 0/20 ND
Meningoencephalitis
PO Normal control 39 F - - ND 0/66HAFLER ET AL.
￿
1315
allogeneic mononuclear feeder cells (obtained from a single healthy donor) per well, 0.5
jug/ml PHA, and 10% TCGF or 5% IL-2. Growth-positive wells, ascertained by micro-
scopic analysis, were split, followed 3-4 d later by transfer of cells back into 96-well V-
bottomed plates with 5,000 T cells per well and 105 irradiated, allogeneic, mononuclear
feeder cells, again with PHA and TCGF or IL-2. After 5-10 d of growth, T cell clones
were transferred to 25-ml tissue culture flasks (Flow Laboratories, Inc.) at a cell concen-
tration of 106 cells/ml. Certain clones have remained stable for > 1 yr after restimulation
with allogeneic feeder cells, PHA, and IL-2 at 10-14-d intervals. Cloning efficiency of
the CSF and blood T cells were similar to previous studies and ranged from 20 to 98%
(10).
mAbs and T Cell Phenotyping.
￿
Analysis of T cell surface antigens was performed by
direct immunofluorescence using fluorescein-conjugated anti-CD4 and anti-CD8 n Abs
(Coulter Immunology, Hialeah, FL), followed by flow cytometry on an Epics C analyzer
as previously described (3).
Southern Blot Analysis.
￿
Genomic DNA extractions were performed according to stan-
dard methodology (14). DNA was digested with the restriction enzyme Eco RI or Hind
III, size fractionated by electrophoresis through a 0.8% agarose gel, and transferred onto
nitrocellulose by the method of Southern (14). Filters were hybridized to nick-translated
"P-labeled probes of the TCR ,B chain gene and y chain gene and were washed at 60°C
in 0.1% SDS, 0.15 M NaCl, and 0 .0015 M Sodium citrate before autoradiography. DNA
probes were restriction enzyme DNA fragments of previously cloned germline T cell anti-
gen receptor 0 chain genes (15). Je, is a 2 .6-kb Hind III-Nai I fragment containing the
J,,, gene segment cluster; Jet are contiguous 1 .9-kb Pvu II-Pvu II and 1 .5-kb Pvu II-Eco
RV fragments containing the 3' half of the Jet gene segment cluster. The two probes do
not crosshybridize. J, is a 0.8-kb Hind III-Eco RI fragment containingJ,, . It hybridizes
to both the J,1 and J,2 gene segments (8).
Results
The pattern of TCR ,B chain and y chain gene rearrangements for each of the
clones was determined by Southern blot analysis using DNA probes specific for
the Jq,, Js2, and J, gene segment clusters. A representative set of the Southern
blots are shown to demonstrate that these clones can be distinguished from one
another (Fig. 1). Of the >250 DNA samples examined, ^-5% were observed to
have more than two different rearranged fragments hybridized to either the Js,
or Js2 probe (see clone 37, Figure 1 B). We have assumed that these samples
were derived from cell cultures in which more than one T cell was originally
cultured; none of these samples were included in the analysis of T cell clono-
types. Furthermore, we found that the amount of hybridization to restriction
fragments in the germline configuration varied between DNA samples, (e.g., the
4.4-kb germline Js2 Eco RI fragment in Fig. 2). This occurred because of the
contribution in each sample of DNA from varying numbers of irradiated, mono-
nuclear feeder cells.
We examined the pattern of ,B chain and y chain gene rearrangements of 318
independently derived T cell clones from three subjects with MS, two subjects
with other inflammatory diseases of the CNS, and from the blood of a normal
subject. The DNA from 28 independent CSF-derived T cell clones from subject
GR were digested with the restriction enzyme Eco RI and hybridized in separate
experiments with three TCR gene probes: J01, J#2, and J,,. The restriction frag-
ment patterns of each clone were compared with the pattern produced by all
the other clones to determine if any two clones were identical to one another.
Identity of two cloned T cells could not be determined by comparison of restric-1316
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FIGURE 2 .
￿
Identical pattern of Jsz gene segment
rearrangement in T cell clones derived from the CSF
of patient GR with chronic progressive MS . The iden-
tical pattern of two rearranged DNA fragments
hybridizing to the J02 probe is shown for 7/8 CSF-
derived T cell clones displaying this pattern. These
clones have one rearranged DNA fragment hybridiz-
ing to the J0, probe as exemplified by clone33 in Fig.
I in addition to an identical rearrangement pattern
of theJ ., gene segment (not shown) . Because of the
contribution of varying amounts of irradiated, mono-
nuclear feeder cell DNA, the 4.4-kb Eco RI DNA
fragment, containing the germlineJsl gene segment
cluster, appears in varying intensity in the different
samples .
tion fragments identified by a single probe . That is, two clones may produce
comigrating fragments on the basis of chance . To eliminate this possibility,
Southern blots were hybridized with a second independent probe . The possibil-
ity that two different clones would produce two comigrating fragments is
extremely unlikely . Finally, the use of a third independent probe (J,), as used in
these experiments, should completely eliminate the possibility that two different
clones would appear identical by chance alone . Of the 28 CSF clones from sub-
ject GR, there were five sets of gene rearrangement patterns identified among
more than one clone ; each set of unique patterns consisted of rearrangements
observed in different experiments with Jgt, J02, and J, probes . One set of gene
rearrangement patterns identified in different experiments with Jst, Js2, J,
probes (clone 33, Fig . 1) was found in 8 of the 28 clones studied. This clonotype
is shown for seven of the eight clones in Fig. 2. Other sets of common gene
rearrangements were observed in the CSF of subject GR, and they are summa-
rized in Table I. Two sets of common rearrangement patterns were each found
twice among the 26 independent blood-derived T cell clones from subject GR
(Table 1) . One clonotype was found in one CSF-derived T cell clone and one
blood-derived T cell clone (data not shown) . All of the clones with common TCR
gene rearrangements were CD4+, CD8- .
27 clones were established from another patient (KA) with chronic progressive
MS . One set of common rearrangement patterns using Ja , , J#2, and J, probes
after an Eco R1 digest was found among three clones, and another among two
clones . Fig . 3 is a Southern blot that shows the identical rearrangement patterns
FIGURE 3 .
￿
Identical patterns of J02 gene segment
rearrangements after Hind III enzyme digest in sep-
arate T cell clones derived from the CSF of patient
KA with chronic progressive MS . In addition, identi-
cal patterns of Ja,, Jaz, and J, gene segment rear-
rangements were observed from CSFT cell clones of
subject KA after Eco RI digest and hybridization with
J0,, Jaz, and J, probes (not shown) . This was con-
firmed by an additional digest of genomic DNA with
the restriction enzyme Hind III and hybridization to
the J0 1, Jrr, and J, probes U02 shown above) .1318
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of T cell clones from subject KA after digestion and hybridization of genomic
DNA with an additional restriction enzyme (Hind III) and TCR gene probe (Js2)
combination.
41 and 37 clones were generated from blood and CSF, respectively, of subject
MU with acute, fatal MS. There were no common rearrangement patterns
observed among the blood- and CSF-derived T cell clones.
34 blood-derived and 33 CSF-derived T cell clones were generated from a
subject with SSPE, 20 clones were generated from the CSF of a subject with
HZV meningoencephalitis, and 66 clones were generated from the blood of a
normal subject (Table I). There were no common ,B chain gene rearrangements
observed indicating that these were polyclonal T cell populations in the CSF and
blood.
Discussion
in these experiments, T cells were directly cloned from the CSF and blood of
patients with MS and other inflammatory CNS diseases before other in vitro
manipulation and were compared by Southern blot analysis of the rearrange-
ment of their T cell antigen receptor a chain and y chain genes. We found there
was clonal expansion of T cell populations in the CSF of two patients with
chronic progressive MS, as compared with the CSF of subjects with other
inflammatory CNS disease, a patient with acute, fatal MS, or normal peripheral
blood. In one patient with progressive MS, two identical clones were isolated
from the peripheral blood.
Southern blotting has a limited ability in differentiating two restriction frag-
ments that have migrated on an agarose gel. Thus, in the type of analysis pre-
sented in these experiments, it is important to use more than one restriction
enzyme or probe to prove that two clones have identical rearrangements. For
these experiments, we used two enzymes and three different DNA probes that
identify rearrangements of TCR genes to determine the relationship between
different T cell clones. We estimate that these probes allow us to determine if
two T cell clones are identical and thus derived from a common progenitor with
a very high level of confidence (p > 0 .001) based on the resolution of agarose
gels with Southern blotting and with the use of different probe and restriction
enzyme combinations, each of which gives an independent assessment of clon-
ality. In addition, the analysis has been confirmed by the recent identification
of the V gene group used by the eight clones shown in Fig. 2, where we found
that the same V gene is used (Hafler, D. A., and A. D. Duby, manuscript in
preparation).
Clonal T cell expansion has most commonly been demonstrated in T cell
malignancies and T cell lymphocytosis with cytopenia (16-19). Oligoclonal T
cells have not generally been found in studies examining the T cell response to
foreign antigens (20), although certain V-DJ sequences of TCR /3 chain genes
may preferentially be used in the T cell response (21). It is as yet unknown
whether the clonally expanded CSF T cell populations represent discrete anti-
genic specificities against certain antigenic determinants (21). Nonetheless, the
analysis presented here demonstrates for the first time to our knowledge thatHAFLER ET AL.
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accumulation and/or expansion of clonal populations of T cells can occur in an
immune compartment such as CSF during the course of a nonmalignant inflam-
matory response.
Attempts to define the specificity of CSF T cells found in MS patients have
been unsuccessful (1, 2). In previous experiments (10, 22, 23), we and others
have been unable to demonstrate T cell clones derived by single cell cloning
from the peripheral blood, CSF, and brain tissue of MS patients that proliferate
in response to myelin basic protein or proteolipid protein. The oligoclonal CSF
T cells we have identified may reflect pathologic autoreactive clones to an as yet
undefined antigen important in the initiation or mediation of demyelination.
Alternatively, the oligoclonal population of T cells in the CSF may reflect the
chronic nature of the disease process with local proliferation of T cells that play
no pathogenic role. Nevertheless, our data indicate that limited specificities may
exist among the CSF T cell populations in chronic progressive MS patients,
although their clinical importance is as yet unknown .
The oligoclonal T cells that we isolated were CD4+,CD8-. Because CD4+ cells
can be either helper inducer, suppressor inducer, or class 11 MHC antigen-
restricted cytotoxic effector cells, it is not possible to ascribe a particular cell
function to our T cell clones (24). Whether these clonally expanded T cells are
antigen-reactive inducer cells or cytotoxic effector cells is an important question
that is presently under investigation.
Oligoclonal Ig banding found in MS CSF remains unexplained (4, 5). The
oligoclonal CSF T cells that we observed could be related to, or responsible for,
this oligoclonal Ig production, and studies are now in progress to determine
whether the oligoclonal T cells are specifically directing the oligoclonal B cell
synthesis of CSF antibodies in MS.
The presence of clonal expansion of CSF lymphocytes from the first two
chronic progressive MS patients examined, and the absence of this finding in
the subject (MU) with acute fatal MS is of interest. It is possible that either the
acute nature of his disease or previous immunosuppression may have influenced
the frequencies of the CSF T cell population. Alternatively, oligoclonal popula-
tions may have been present in acute MS and subjects with the inflammatory
CNS diseases but represented too small a fraction of the total T cell population
to be detected by this methodology. Of note is a recent study of two MS patients
in which oligoclonal T cells were not detected in the CSF (25). Further studies
on larger series of patients are necessary to examine whether clonal T cell
expansion in MS CSF is a rare or frequent event.
Given the results we have obtained, further analysis of T cells from the CSF
of MS patients should also define: (a) whether the appearance of oligoclonal T
cells is an early or late event in the evolution of MS; (b) whether there is cross-
reactivity between oligoclonal TCR clonotypes from different MS patients; and
(c) whether there are common variable region TCR genes found in higher fre-
quencies among different MS patients. The approach described here also has
general applications for examining the clonality of T cells in the immune com-
partments of other inflammatory diseases, such as rheumatoid arthritis, autoim-
mune thyroiditis, transplant rejection, and insulin-dependent diabetes mellitus.
Further examination of expanded TCR clonotypes in immune compartments1320
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and their relationship to antigenic specificities may be of importance in attempt-
ing to further understand the cellular immune response in inflammatory human
diseases.
Summary
We have investigated the T cell populations in the cerebrospinal fluid (CSF)
of chronic progressive multiple sclerosis (MS) patients. Individual T cells from
the CSF and blood were cloned before expansion and their clonotypes were
defined by analysis of rearranged T cell receptor ,0 chain and ,y chain genes. 87
T cell clones from blood and CSF of two patients with chronic progressive MS
were examined for common TCR gene rearrangement patterns. In one patient,
18 of 28 CSF-derived T cell clones demonstrated common TCR gene rearrange-
ments indicating oligoclonal T cell populations ; in the blood, two patterns were
found twice among 26 T cell clones. In another patient, 5 of 27 CSF-derived
clones had common TCR gene rearrangement patterns. In contrast, no common
(3 chain rearrangement pattern was found among 67 T cell clones derived from
the blood or CSF of a patient with subacute sclerosing panencephalitis, among
20 clones from the CSF of a patient with herpes zoster meningoencephalitis, or
among 66 clones from a normal subject. A subject with atypical, fatal MS of 8-
mo duration was also studied and did not have oligoclonal T cells in the CSF or
blood. These results demonstrate that distinct oligoclonal T cell populations can
be found in the CSF immune compartment of subjects with nonmalignant
inflammatory disease and they can create a new avenue for the investigation of
the specificity of the T cell response within the central nervous system.
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Note added in proof. Similar to our findings in the cerebrospinal fluid, oligoclonal pop-
ulations of T cells have also recently been demonstrated in synovial membranes, but not
in blood of subjects with rheumatoid arthritis, another nonmalignant inflammatory dis-
ease (26) .
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